세계의 척추만곡증 시장(2023-2030년)

Overview

Global Kyphoscoliosis Market reached US$ 2.9 billion in 2022 and is expected to reach US$ 4.2 billion by 2030, growing with a CAGR of 5.1% during the forecast period 2023-2030.

Kyphoscoliosis is an abnormal curve of the spine on two planes: the coronal plane, or side to side, and the sagittal plane, or back to front. It's a combined spinal abnormality of two other conditions: kyphosis and scoliosis. Scoliosis causes an abnormal coronal plane curvature, which causes the spine to curve horizontally.

By improperly twisting forward or backward on the sagittal plane, kyphosis causes the back to seem rounded or fell. The development of patient-specific implants and surgical planning tools, typically assisted by 3D printing and computer-assisted design, can improve surgical outcomes by customising operations for each patient. Treatment options include physical therapy, bracing, and in severe situations, surgery. These procedures aim to reduce discomfort while also improving posture and mobility.

Dynamics

The Rise of Neurological Disorders

Neurological disorders can easily influence the onset and evolution of kyphoscoliosis due to their effects on muscle control, coordination, and general neuromuscular function. Neurological diseases including muscular dystrophy and spinal muscular atrophy frequently present with muscle weakness. Weak muscles are unable to provide the spine with the necessary support to maintain its natural posture and curvature. Atypical spinal curvatures, such kyphoscoliosis, may arise as a result of this weakening.

Some neurological conditions, such as spinal cord tumours or trauma, can directly compress the spinal cord or injure it. By interfering with the regular brain impulses that control muscle function and posture, this compression has the potential to result in spinal anomalies such kyphoscoliosis. Therefore, the increase of neurological disorders will boost market growth.

For instance, according to a recent United Nations report, up to 1 billion people, or nearly one in six of the world's population, suffer from neurological disorders, including migraine, brain injuries, and neuroinfections as well as diseases like Alzheimer's and Parkinson's, stroke, multiple sclerosis, and epilepsy. Each year, 6.8 million people suffer as a result of these illnesses. Thus, the rise in neurological conditions contributes to the market's rapid expansion.

Technological Advancements in the Treatment

The diagnosis, treatment, and management of kyphoscoliosis have all benefited greatly from technological improvements. These developments have increased our understanding of the disorder, improved the capacity to diagnose it, and provided better therapy options.

For instance, a common medical device, particularly in spinal surgery, is the MAGEC system. In order to slow the progression of scoliosis, the spine is braced during growth. Paediatric patients make up a large portion of the patients receiving this treatment. A safety notice was issued on February 13, 2020, in response to complaints of post-implantation separation of an actuator end cap in MAGEC system Model X rods. The data evaluation revealed that the actuator end cap separation had happened in about 0.5% of the devices, prompting doctors to stop all system implantations.

Physicians have been cautioned that after the end cap has separated, the implant may become loose, corrode, migrate, or cause pain, and that the rod may continue to extend or distract while acting as an internal brace. This could result in the actuator's internal components becoming exposed, which could speed their deterioration and allow titanium alloy, wear debris, and localised tissue discoloration to enter the system.

Side Effects Associated with the Treatment

Kyphoscoliosis can be treated in a number of ways, including bracing, physical therapy, and surgery, depending on the severity of the condition and the patient's specific needs. There are several potential side effects and considerations specific to each form of treatment. An extended period of wearing a brace may result in skin rashes, chafing, or pressure sores.

Padding and a proper fit could mitigate this issue. Physical therapy exercises may cause muscle soreness, especially when starting a new exercise routine. Patients may experience pain and discomfort at the surgical site for several weeks or months after the procedure. Pain control is a crucial part of postoperative care.

Segment Analysis

The global kyphoscoliosis market is segmented based on type, disease management, age group, end user and region.

Kyphoscoliosis can Affect Children more Easily than Adults

Kyphoscoliosis can affect children more easily than adults due to a number of issues associated to the developing spine and musculoskeletal system during childhood and adolescence. For instance, certain children have a higher risk of developing kyphoscoliosis due to congenital spine abnormalities. These anomalies might not be identified until the child's spine begins to grow and develop.

The ligaments and soft tissues that surround the spine also grow swiftly in children and teenagers. These structures may not develop properly or expand at different rates, which can cause kyphoscoliosis. Children and teenagers are more likely to participate in activities that strain the spine excessively or adopt poor postural habits. Large backpacks, protracted use of electronic gadgets while hunched over, and various badly performed tasks can strain the spine and possibly result in kyphoscoliosis. Thus, all of those factors contribute to accelerating segment expansion.

Geographical Penetration

Rising Product Approvals and Prevalence of Disease in the North American Region

A mix of historical, economic, and societal factors have contributed to the great advancement of healthcare services in North America, especially in the United States and Canada. In North America, regulatory organisations like the Food and Drug Administration (FDA) in the United States and Canada set strict guidelines for the effectiveness and safety of medications and medical devices. These organisations aid in ensuring that only secure and efficient medications are distributed.

Moreover, numerous medical research organisations, academic institutes, and healthcare facilities located in North America are at the forefront of spine-related research. To learn more about the origins, risk factors, and available treatments for kyphoscoliosis, researchers in the area are actively researching the condition. Clinical trials are required because of this area of research interest. North America is the perfect site for conducting clinical trials due to its sophisticated healthcare system and medical technologies. Clinical research can be carried out with the help of modern facilities, qualified medical personnel, and advanced imaging technology. Thus, all of these variables contribute to the region's growth.

COVID-19 Impact Analysis

Many healthcare systems had issues and delays in non-urgent care during the pandemic, including the diagnosis and treatment of kyphoscoliosis. Routine tests, imaging, and elective treatments were postponed or cancelled in a number of locations, which would have delayed the diagnosis and treatment of some patients.

Patients who rely on orthopaedic braces for their kyphoscoliosis therapy may have experienced difficulties getting their braces fitted, adjusted, or replaced when hospitals cut back on their services or during lockdowns. This could impact the effectiveness of bracing therapies. During periods of high COVID-19 activity, elective treatments, such as those to treat kyphoscoliosis, were routinely delayed to save money on medical services and reduce the risk of viral transmission in hospitals. As a result, individuals who require surgery could have to wait longer.

By Type

• Scoliosis
• Kyphosis
  • Postural kyphosis
  • Scheuermann's kyphosis
  • Age-related kyphosis
  • Congenital kyphosis

By Disease Management

• Diagnosis
  • MRI
  • CT Scan
  • Bone Density Testing
  • Others

• Medication
• Surgery
  • Spinal Implants
  • Bone Grafts
  • Braces and Orthotics
  • Others

By Age Group

• Children
• Adults

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• On July 05, 2022, an advanced surgery was recently performed by a skilled team of surgeons from the city's top multispecialty hospital, SIMS Hospital India, to treat a severe case of kyphoscoliosis. The spine surgery community refers to the 15-year-old Ethiopian patient, Master Tesfaye Mengesha Mersha, who has severe kyphoscoliosis, as having a "Anaconda Spine," a 110-degree deformity of the upper spine in the chest area.
• On September 22, 2021, the first surgical procedure in the BRAIVE IDE study, which will assess the safety and efficacy of the BraiveTM growth modulation system for the treatment of progressive juvenile (JIS) or adolescent (AIS) idiopathic scoliosis, has been completed, according to Medtronic plc, the world leader in medical technology.

Competitive Landscape

The major global players in the market include Koninklijke Philips N.V., Canon, GE Healthcare, Siemens, Hologic, Sri Krishna Pharmaceuticals Ltd, NEXGEN PHARMA INC, ValiantLabs.in., BASF Corporation, Dr. Reddy's Laboratories Ltd and among others.

Why Purchase the Report?

• To visualize the global kyphoscoliosis market segmentation based on type, disease management, age group, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of kyphoscoliosis market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global kyphoscoliosis market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Disease Management
• 3.3. Snippet by Age Group
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The rise of Neurological disorders
    • 4.1.1.2. Technological advancements in the Treatment
• 4.2. Restraints
  • 4.2.1.1. Side effects associated with the treatment
  • 4.2.2. Opportunity
  • 4.2.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Scoliosis *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Kyphosis
  • 7.3.1. Postural kyphosis
  • 7.3.2. Scheuermann's kyphosis
  • 7.3.3. Age-related kyphosis
  • 7.3.4. Congenital kyphosis

8. By Disease Management

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
  • 8.1.2. Market Attractiveness Index, By Disease Management
• 8.2. Diagnosis*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.2.1. MRI
    • 8.2.2.2. CT Scan
    • 8.2.2.3. Bone Density Testing
    • 8.2.2.4. Others
• 8.3. Medication
• 8.4. Surgery
  • 8.4.1. Spinal Implants
  • 8.4.2. Bone Grafts
  • 8.4.3. Braces and Orthotics
  • 8.4.4. Others

9. By Age Group

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 9.1.2. Market Attractiveness Index, By Age Group
• 9.2. Children*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Adults

10. By End User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.1.2. Market Attractiveness Index, By End User
• 10.2. Hospitals*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Clinics
• 10.4. Ambulatory Surgical Centres

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.6.1. U.S.
    • 11.2.6.2. Canada
    • 11.2.6.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. UK
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles (1-5 Diagnosis Device Manufacturers & 6-10 Drug Manufacturers)

• 13.1. Koninklijke Philips N.V. *
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Canon
• 13.3. GE Healthcare
• 13.4. Siemens
• 13.5. Hologic
• 13.6. Sri Krishna Pharmaceuticals Ltd
• 13.7. NEXGEN PHARMA INC
• 13.8. ValiantLabs.in.
• 13.9. BASF Corporation
• 13.10. Dr. Reddy's Laboratories Ltd

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us